Results 361 to 370 of about 2,974,682 (398)

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Rolipram, a specific type‐4 phosphodiesterase inhibitor, inhibits cyclophosphamide‐induced haemorrhagic cystitis in rats

BJU International, 2009
M. Sakura, H. Masuda, Y. Matsuoka, M. Yokoyama, S. Kawakami, K. Kihara   +5 more
semanticscholar   +1 more source

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Nature, 2020
Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly  

Cell junction and cyclic AMP: I. Upregulation of junctional membrane permeability and junctional membrane particles by administration of cyclic nucleotide or phosphodiesterase inhibitor

Journal of Membrane Biology, 1981
J. Flagg-Newton, Gerhard Dahl, Werner R. Loewenstein   +2 more
semanticscholar   +1 more source

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Phosphodiesterase inhibitors

2007
openaire   +2 more sources

Effects of cyclic nucleotides on deoxyribonucleic acid synthesis in hypophysectomized rat cartilage: stimulation of thymidine incorporation and potentiation of the action of somatomedin by analogs of adenosine 3',5'-monophosphate or a cyclic nucleotide phosphodiesterase inhibitor.

Endocrinology, 1980
J. D. Bomboy, W. Salmon
semanticscholar   +1 more source

Phosphodiesterase Inhibitors

1996
openaire   +2 more sources

The phosphodiesterase inhibitor ‘war’

BJU International, 2003
openaire   +2 more sources